Emergent BioSolutions awarded 10-Year BARDA contract valued at $704 million for Ebanga treatment for Ebola
On Jul. 31, 2023, Emergent BioSolutions announced that it was awarded a 10-year contract by the Biomedical Advanced…
-
-
Scientists developed breath test that rapidly detects COVID-19 virus
On Jul. 31, 2023, scientists at Washington University in St. Louis have developed a breath test that quickly…
-
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO
Circulating vaccine-derived poliovirus type 2 reported in United Republic of Tanzania and Kenya
On Jul. 28, 2023, the World Health Organization (WHO) reported circulating vaccine-derived poliovirus type 2 (cVDPV2) in the…
-
Feinstein Institutes researchers first to use double neural bypass to restore movement in man living with quadriplegia
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Healthﾒs…
-
Biotechnology | FDA | Vaccine
U.S. FDA approved Ervebo first U.S.-licensed vaccine for prevention of Ebola virus disease
On Jul. 28, 2023, the U.S. Food and Drug Administration (FDA) approved Merck’s Ervebo, a vaccine for the…
-
Genome analysis of revived 46,000-year-old roundworm from Siberian permafrost revealed a novel species
On Jul. 28, 2023, researchers from the Institute of Zoology at the University of Cologne, the Max Planck…
-
CIRM invested $50 million in clinical-stage research
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…
-
WHO reported influenza A(H5N1) identified in cats across Poland
On Jul. 27, 2023, the IHR National Focal Point of Poland notified WHO of unusual deaths in cats…
-
SIGA announced U.S. Government procurement orders of approximately $138 million for oral and IV TPOXX
On Jul. 27, 2023, SIGA Technologies announced that the U.S. Department of Health and Human Services exercised procurement…
-
Milestones in Diabetes
Milestones in Diabetes illustrates major milestones from the first administration of the hormone insulin in 1921 to a…
-
JAMA reported excess death rates for Republican and Democratic voters in Florida and Ohio during COVID-19 pandemic
On Jul. 24, 2023, the Journal JAMA reported there is evidence that Republican-leaning counties had higher COVID-19 death…
-
Biotechnology | COVID-19 | Disease | WHO
Middle East Respiratory Syndrome reported in United Arab Emirates
On Jul. 24, 2023, the United Arab Emirates (UAE), notified WHO of a case of Middle East Respiratory…
-
First case of Candida auris reported in Washington with local transmission suspected
On Jul. 19, 2023, the King County Department of Health issued a Health Advisory that Candida auris (C….
-
NIH released new atlas of human kidney cells to help unlock kidney disease research
On Jul. 19, 2023, the National Institute of Health announced that a nationwide research team had created the…
-
U.S. FDA approved Veklury (Remdesivir) for COVID-19 treatment in patients with Severe renal impairment
On Jul. 14, 2023, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Therapeutics | Vaccine | Veterinary
UK Animal and Plant Health Agency reported asymptomatic human detections of influenza A (H5N1)
On Jul. 14, 2023, the UK Animal and Plant Health Agency reported that additional asymptomatic human detections of…
-
Perrigo announced U.S. FDA approval for Opill OTC daily oral contraceptive
On Jul. 13, 2023, Perrigo announced that the U.S. Food and Drug Administration had approved Opill, a progestin-only…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA granted traditional approval for LEQEMBI (lecanemab-irmb) for the treatment of Alzheimer’s disease
On Jul. 6, 2023, Eisai and Biogen announced that the U.S. Food and Drug Administration (FDA) had approved the…
-
University of Illinois Urbana-Champaign team developed all-species coronavirus test
On Jul. 6, 2023, University of Illinois Urbana-Champaign researchers reported they can detect exposure to the SARS-CoV-2 virus…
-
18 million doses of first-ever malaria vaccine allocated to 12 African countries for 2023-2025
On Jul. 5, 2023, the IHR National Focal Point of Poland notified WHO of unusual deaths in cats…
-
Biotechnology | Diagnostics | Disease | FDA | Rare Disease | Therapeutics
U.S. FDA approved BioMarin’s ROCTAVIAN, the first and only gene therapy for adults with severe hemophilia A
On Jun. 29, 2023, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy…
-
Breakthrough Gene Therapy Offers Hope for Severe Developmental Epilepsy in Children
On Jun. 27, 2023, researchers from Tel Aviv University announced they have developed an innovative gene therapy that…
-
CDC flu vaccination recommendations adopted for 2023-2024 season
On Jun. 27, 2023, the U.S. Centers for Disease Control and Prevention (CDC) adopted the 2023-2024 Advisory Committee…
-
First U.S.-based Canine Cancer Registry joined international network to help advance canine and human cancer research
On Jun. 26, 2023, Jaguar Health announced that the Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) had joined…
-
AquaBounty Announced a Pause to Ohio Farm Construction While It Evaluated Alternatives
On Jun. 22, 2023 AquaBounty Technologies announced that the Company will pause the construction of its farm in…
-
IHME reported global diabetes cases to soar from 529 million to 1.3 billion by 2050
On Jun. 22, 2023, the Institute for Health Metrics and Evaluation (IHME) reported that more than half a…
-
Biotechnology | Disease | FDA | Medicine | Therapeutics
U.S. FDA approved first gene therapy for treatment of patients with Duchenne Muscular Dystrophy
On Jun. 22, 2023, the U.S. Food and Drug Administration (FDA) approved Sarepta Therapeutics’s Elevidys, the first gene…
-
Donald Triplett, the 1st person diagnosed with autism, died at 89
On Jun. 17, 2023, the Mississippi man known as “Case 1,” the first person to be diagnosed with…
-
U.S. FDA updated COVID-19 vaccines for use in the U.S. beginning in Fall 2023
On Jun. 16, 2023, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee…
-
U.S. FDA permitted marketing of first COVID-19 at-home test using traditional premarket review process
On Jun. 6, 2023, the U.S. Food and Drug Administration (FDA) granted granted marketing authorization for the Cue COVID-19…
